Assessment of thyroid function during and after treatment of thyrotoxicosis.
作者信息
McLarty D G, Alexander W D
出版信息
J Clin Pathol. 1975 Mar;28(3):251-4. doi: 10.1136/jcp.28.3.251.
Abstract
摘要
相似文献
1
Assessment of thyroid function during and after treatment of thyrotoxicosis.甲状腺毒症治疗期间及治疗后的甲状腺功能评估。
J Clin Pathol. 1975 Mar;28(3):251-4. doi: 10.1136/jcp.28.3.251.
2
Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.甲状腺毒症抗甲状腺药物治疗长期疗效的预测
J Clin Endocrinol Metab. 1970 Apr;30(4):540-3. doi: 10.1210/jcem-30-4-540.
3
Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.用三碘甲状腺原氨酸进行甲状腺抑制作为抗甲状腺药物治疗甲状腺毒症疗程的指导
Lancet. 1966 Nov 12;2(7472):1041-4. doi: 10.1016/s0140-6736(66)92024-1.
4
Treatment of thyrotoxicosis based on thyroidal suppressiblity.基于甲状腺抑制性的甲状腺毒症治疗。
Lancet. 1967 Sep 30;2(7518):681-4. doi: 10.1016/s0140-6736(67)90972-5.
5
Evaluation of the triiodothyronine suppression test in the treatment of Graves' disease.三碘甲状腺原氨酸抑制试验在格雷夫斯病治疗中的评估。
Eur J Clin Invest. 1970 Aug;1(2):90-3. doi: 10.1111/j.1365-2362.1970.tb00602.x.
6
Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.停用抗甲状腺药物长期治疗甲状腺毒症后的甲状腺抑制性
Metabolism. 1969 Jan;18(1):58-62. doi: 10.1016/0026-0495(69)90133-4.
7
Treatment of thyrotoxicosis with lithium carbonate.碳酸锂治疗甲状腺毒症
Lancet. 1974 Nov 16;2(7890):1160-3. doi: 10.1016/s0140-6736(74)90808-3.
8
Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.抗甲状腺药物治疗甲状腺毒症后碘有机化缺陷。
Clin Endocrinol (Oxf). 1975 Jul;4(4):357-62. doi: 10.1111/j.1365-2265.1975.tb01544.x.
9
Five-year follow-up of thyrotoxicosis treated with antithyroid drugs.抗甲状腺药物治疗甲状腺毒症的五年随访
Endokrinologie. 1974 Sep;63(3):325-30.
10
[Clinical significance of determination of early thyroidal 131-I uptake rate--relationship with 24-hour 131-I uptake rate].早期甲状腺 131碘摄取率测定的临床意义——与 24 小时 131 碘摄取率的关系
Horumon To Rinsho. 1972 Feb;20(2):107-14.
引用本文的文献
1
Goiter: an approach to management.甲状腺肿：一种管理方法。
Can Fam Physician. 1978 Apr;24:371-5.
本文引用的文献
1
Clinical and metabolic studies in thyroid disease.甲状腺疾病的临床与代谢研究。
Br Med J. 1960 Jan 9;1(5166):78-90. doi: 10.1136/bmj.1.5166.78.
2
Later results of 131-I treatment of hyperthyroidism in 73 children and adolescents: 1967 followup.131碘治疗73例儿童及青少年甲状腺功能亢进症的远期结果：1967年随访。
J Nucl Med. 1969 Sep;10(9):586-90.
3
The changing iodide-uptake test.动态碘摄取试验
N Engl J Med. 1969 Jun 26;280(26):1474-5. doi: 10.1056/NEJM196906262802610.
4
Thyroidectomy in the management of thyrotoxicosis in the adolescent.青少年甲状腺毒症的甲状腺切除术治疗
Surgery. 1969 Apr;65(4):694-9.
5
Scottish automated follow-up register for thyroid disease: four years' experience in Glasgow.苏格兰甲状腺疾病自动随访登记：格拉斯哥的四年经验
Br Med J. 1974 Jun 1;2(5917):490-2. doi: 10.1136/bmj.2.5917.490.
6
Sequential assessment during drug treatment of thyrotoxicosis.甲状腺毒症药物治疗期间的序贯评估。
Clin Endocrinol (Oxf). 1973 Jan;2(1):43-50. doi: 10.1111/j.1365-2265.1973.tb03483.x.
7
Studies of thyroid function using 99Tcm in thyrotoxic patients during treatment with antithyroid drugs.在抗甲状腺药物治疗期间，使用99锝研究甲状腺毒症患者的甲状腺功能。
Clin Endocrinol (Oxf). 1973 Jan;2(1):65-73. doi: 10.1111/j.1365-2265.1973.tb03486.x.
8
Changing normal values for thyroidal radioiodine uptake.甲状腺放射性碘摄取正常数值的变化。
N Engl J Med. 1969 Jun 26;280(26):1431-4. doi: 10.1056/NEJM196906262802602.
Zotero 插件